# Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas

> **NCT02041611** · NA · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 20 (actual)

## Conditions studied

- High Grade Glioma

## Interventions

- **PROCEDURE:** Blood collections

## Key facts

- **NCT ID:** NCT02041611
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-13
- **Primary completion:** 2013-09-02
- **Final completion:** 2015-12-17
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02041611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02041611, "Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02041611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*